Baseline urate level and renal function predict outcomes of urate-lowering therapy using low doses of febuxostat and benzbromarone: a prospective, randomized controlled study in a Chinese primary gout cohort

BACKGROUND: Low doses of febuxostat or benzbromarone are widely used in Asian countries, but lacking studies to compare the efficacy and safety of the two urate-lowering drugs. METHODS: To compare the efficacy and safety of low-dose febuxostat with low-dose benzbromarone in patients with primary gou...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Nan, Sun, Mingshu, Sun, Ruixia, Xu, Ting, Cui, Lingling, Wang, Can, Ma, Lidan, Cheng, Xiaoyu, Xue, Xiaomei, Sun, Wenyan, Yuan, Xuan, Zhang, Hui, Li, Hailong, He, Yuwei, Ji, Aichang, Wu, Xinjiang, Li, Changgui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719374/
https://www.ncbi.nlm.nih.gov/pubmed/31477161
http://dx.doi.org/10.1186/s13075-019-1976-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719374/
https://www.ncbi.nlm.nih.gov/pubmed/31477161
http://dx.doi.org/10.1186/s13075-019-1976-x

Ejemplares similares